The hepatitis B virus core protein (HBc) increased NEU1 gene promoter activity through NF-κB binding sites, leading to activation of ERK1/2 and NF-κB signaling pathways, and increased HBc-mediated migration and proliferation of hepatoma cells (269). Here, KRT88P is linked to hepatocellular carcinoma.